Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 559.65
-0.367 %
$ 214 B
Market Cap
35.09
P/E
TMO - REVENUE
Revenue TMO - Thermo Fisher Scientific Inc.
42.9 B
LAST VALUE
4.55%
2 YEAR CAGR
11.96%
5 YEAR CAGR
12.59%
10 YEAR CAGR